In a landmark initiative, the Sant Joan de Déu Hospital in Barcelona and La Caixa Foundation have signed a strategic agreement to address pediatric minority diseases, marking a milestone in the research and treatment of these conditions.
The alliance, which is shaping up to be a long-term collaboration, aims to accelerate diagnostics, increase available therapies and improve the quality of life of affected patients.
La Caixa Foundation will support the research carried out by the Hospital Sant Joan de Déu with a significant investment. 7.5 million euros will be allocated over the next three years, thus helping to promote projects that address these diseases in a comprehensive manner.
This financial collaboration will allow the hospital to continue leading research in this field and to coordinate a network of 30 centers throughout Spain dedicated to these pathologies.
The fundamental role of the Hospital Sant Joan de Déu
Hospital Sant Joan de Déu is a leading institution in the treatment of pediatric minority diseases in Europe. Caring for more than 28,000 active patients with 1,400 different pathologies, the hospital plays an essential role in the medical care and research of these conditions.
In addition, the hospital coordinates the Únicas project, an ambitious program that brings together 30 Spanish hospitals to address these diseases from multiple perspectives.
The Únicas project, led by the Hospital Sant Joan de Déu, seeks to create a comprehensive model of care for pediatric patients with rare diseases. This innovative approach encompasses assistance, social, technological and research areas.
The project includes the creation of a platform for data storage and sharing between hospitals, a specialized telemedicine center and a school for caregivers, among other initiatives.
A future of rapid diagnostics and advanced therapies
The agreement between Hospital Sant Joan de Déu and La Caixa Foundation aims to accelerate the diagnosis of patients and increase access to specific therapies, especially those based on advanced and emerging therapies.
The hospital’s managing director, Manel del Castillo, highlights the importance of this comprehensive approach to address pediatric minority diseases, while the president of La Caixa Foundation, Isidro Fainé, emphasizes the commitment of both entities to respond to the challenges posed by these diseases.
This agreement not only represents a significant financial investment in research, but also promises to drive concrete advances in early diagnosis and the development of therapies to improve the quality of life of patients affected by pediatric minority diseases.
The collaboration between Hospital Sant Joan de Déu and La Caixa Foundation is a significant step towards a future in which research and innovation transform the reality of those facing these rare but impactful conditions.